Know Cancer

or
forgot password

    • cancer clinical trials in iowa city, IA

    • Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer
    Holden Comprehensive Cancer Center at The University of Iowa
    Iowa City, Iowa 52242-1009
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Combination Chemotherapy in Treating Children or Adolescents With Newly Diagnosed Stage III or Stage IV Lymphoblastic Lymphoma
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Lymphoma
    506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment
    Holden Comprehensive Cancer Center at The University of Iowa
    Iowa City, Iowa 52242-1009
    Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    Interleukin-12 in Treating Patients With Metastatic or Recurrent Breast Cancer
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Breast Cancer
    Topotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer
    Holden Comprehensive Cancer Center at The University of Iowa
    Iowa City, Iowa 52242-1009
    Endometrial Cancer
    Carboxyamidotriazole in Treating Patients With Advanced Kidney Cancer
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Kidney Cancer
    Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Head and Neck Cancer
    S9901 Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Men With Stage III or Stage IV Hodgkin's Disease
    Holden Comprehensive Cancer Center at The University of Iowa
    Iowa City, Iowa 52242-1009
    Lymphoma
    Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia
    Holden Comprehensive Cancer Center at The University of Iowa
    Iowa City, Iowa 52242-1009
    Lymphoma
    Chemotherapy in Treating Patients With Sarcoma of the Uterus
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Endometrial Cancer, Sarcoma
    Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Prostate Cancer
    Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Cervical Cancer
    Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Endometrial Cancer
    Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial Cancer
    Holden Comprehensive Cancer Center
    Iowa City, Iowa 52242-1009
    Endometrial Cancer
    Comparison of Different Combination Chemotherapy Regimens in Treating Children With Acute Lymphoblastic Leukemia
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Leukemia
    Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia
    Holden Comprehensive Cancer Center at The University of Iowa
    Iowa City, Iowa 52242-1009
    Leukemia
    Combination Chemotherapy in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer
    Holden Comprehensive Cancer Center at The University of Iowa
    Iowa City, Iowa 52242-1009
    Lung Cancer
    Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
    Holden Comprehensive Cancer Center at The University of Iowa
    Iowa City, Iowa 52242-1009
    Leukemia
    Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Endometrial Cancer
    Combination Chemotherapy Plus Trastuzumab in Treating Patients With Advanced, Recurrent, or Metastatic Colorectal Cancer
    Holden Comprehensive Cancer Center
    Iowa City, Iowa 52242-1009
    Colorectal Cancer
    Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Endometrial Cancer
    Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
    Holden Comprehensive Cancer Center
    Iowa City, Iowa 52242-1009
    Lymphoma
    Radiation Therapy With or Without Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Cancer of the Vulva
    Holden Comprehensive Cancer Center at The University of Iowa
    Iowa City, Iowa 52242-1009
    Vulvar Cancer
    Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma
    Holden Comprehensive Cancer Center
    Iowa City, Iowa 52242-1009
    Brain and Central Nervous System Tumors, Lymphoma, Neuroblastoma, Retinoblastoma, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    flt3L in Treating Patients With Acute Myeloid Leukemia
    Holden Comprehensive Cancer Center at The University of Iowa
    Iowa City, Iowa 52242-1009
    Leukemia
    Gemcitabine in Treating Patients With Persistent or Recurrent Cancer of the Cervix
    Holden Comprehensive Cancer Center at The University of Iowa
    Iowa City, Iowa 52242-1009
    Cervical Cancer
    Gemtuzumab Ozogamicin and High-Dose Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Leukemia
    External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer
    Holden Comprehensive Cancer Center at The University of Iowa
    Iowa City, Iowa 52242-1009
    Prostate Cancer
    Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme
    Holden Comprehensive Cancer Center at The University of Iowa
    Iowa City, Iowa 52242-1009
    Brain and Central Nervous System Tumors
    Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer
    Holden Comprehensive Cancer Center at The University of Iowa
    Iowa City, Iowa 52242-1009
    Head and Neck Cancer, Skin Reactions Secondary to Radiation Therapy
    Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Sarcoma
    Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma
    Holden Comprehensive Cancer Center
    Iowa City, Iowa 52242-1009
    Graft Versus Host Disease, Lymphoma
    Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer
    Holden Comprehensive Cancer Center at The University of Iowa
    Iowa City, Iowa 52242-1009
    Colorectal Cancer
    Capecitabine in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cavity Cancer
    Holden Comprehensive Cancer Center at The University of Iowa
    Iowa City, Iowa 52242-1009
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Screening and Diagnostic Trial to Compare the Effectiveness of Two Types of Mammography in Detecting Breast Cancer in Women
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Breast Cancer
    Karenitecin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer
    Holden Comprehensive Cancer Center
    Iowa City, Iowa 52242-1009
    Lung Cancer
    Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the Pancreas
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Pancreatic Cancer
    Nolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Liver Cancer
    Combination Chemotherapy in Treating Patients With Bladder Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Bladder Cancer
    Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV Coinfection
    Univ. of Iowa Healthcare, Div. of Infectious Diseases
    Iowa City, Iowa 52242
    HIV Infections, Hepatitis C
    Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer
    Holden Comprehensive Cancer Center at The University of Iowa
    Iowa City, Iowa 52242-1009
    Endometrial Cancer
    Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
    Holden Comprehensive Cancer Center
    Iowa City, Iowa 52242-1009
    Cervical Cancer
    Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia
    Holden Comprehensive Cancer Center
    Iowa City, Iowa 52242-1009
    Anemia, Cervical Cancer, Drug/Agent Toxicity by Tissue/Organ, Radiation Toxicity
    Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increased Risk
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Ovarian Cancer
    Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
    Lobradimil and Carboplatin in Treating Children With Brain Tumors
    Holden Comprehensive Cancer Center
    Iowa City, Iowa 52242-1009
    Brain and Central Nervous System Tumors
    Tirapazamine Plus Cisplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
    Holden Comprehensive Cancer Center at The University of Iowa
    Iowa City, Iowa 52242-1009
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Rituximab Plus Fludarabine in Treating Patients With Waldenstrom's Macroglobulinemia
    Holden Comprehensive Cancer Center
    Iowa City, Iowa 52242-1009
    Lymphoma
    Chemotherapy and Rituximab With Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Lymphoma
    Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid Leukemia
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Leukemia
    Surgery Versus Internal Radiation in Treating Patients With Stage II Prostate Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Prostate Cancer
    Gefitinib in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    Holden Comprehensive Cancer Center at The University of Iowa
    Iowa City, Iowa 52242-1009
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer
    Holden Comprehensive Cancer Center
    Iowa City, Iowa 52242-1009
    Colorectal Cancer
    Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial Cancer
    Holden Comprehensive Cancer Center
    Iowa City, Iowa 52242-1009
    Endometrial Cancer
    Paclitaxel in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Lymphoma
    Combination Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Pancreatic Cancer
    Irinotecan in Treating Aging Patients With Solid Tumors
    Holden Comprehensive Cancer Center
    Iowa City, Iowa 52242-1009
    Unspecified Adult Solid Tumor, Protocol Specific
    Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Brain and Central Nervous System Tumors
    Fibrin Sealant in Decreasing Lymphedema Following Surgery to Remove Lymph Nodes in Patients With Cancer of the Vulva
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Lymphedema, Perioperative/Postoperative Complications, Vulvar Cancer
    Liposomal Doxorubicin in Treating Patients With Persistent or Recurrent Cancer of the Cervix
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Cervical Cancer
    Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Sarcoma
    Hydroxychloroquine in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Graft Versus Host Disease
    Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Lymphoma